MedPath

Capravirine

Generic Name
Capravirine
Drug Type
Small Molecule
Chemical Formula
C20H20Cl2N4O2S
CAS Number
178979-85-6
Unique Ingredient Identifier
VHC779598X

Overview

No overview information available.

Indication

Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2003/01/23
Phase 2
Completed
2003/01/20
Phase 2
Completed
2001/08/31
Phase 2
Completed
Agouron Pharmaceuticals
2001/08/31
Phase 2
Suspended
Agouron Pharmaceuticals
2001/08/31
Phase 1
Completed
Lexigen Pharmaceuticals
2001/08/31
Phase 2
Suspended
Agouron Pharmaceuticals
2001/08/31
Phase 2
Completed
Agouron Pharmaceuticals
2000/11/24
Phase 1
Completed
2000/05/25
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.